BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Manuel O, Estabrook M; American Society of Transplantation Infectious Diseases Community of Practice. RNA respiratory viral infections in solid organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant 2019;33:e13511. [PMID: 30817023 DOI: 10.1111/ctr.13511] [Cited by in Crossref: 63] [Cited by in F6Publishing: 47] [Article Influence: 21.0] [Reference Citation Analysis]
Number Citing Articles
1 Schreiber A, Elango K, Hong K, Ahsan C. Cardiac transplant recipient with COVID-19 induced acute hypoxic respiratory failure: a case report. Eur Heart J Case Rep 2021;5:ytab217. [PMID: 34189399 DOI: 10.1093/ehjcr/ytab217] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Gentile I, Abenavoli L. COVID-19: Perspectives on the Potential Novel Global Threat. Rev Recent Clin Trials 2020;15:84-6. [PMID: 32116200 DOI: 10.2174/1574887115999200228100745] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
3 Garbo R, Valent F, Gigli GL, Valente M. Pre-Existing Lymphopenia Increases the Risk of Hospitalization and Death after SARS-CoV-2 Infection. Infectious Disease Reports 2022;14:20-5. [DOI: 10.3390/idr14010003] [Reference Citation Analysis]
4 Sweet SC. Community-Acquired Respiratory Viruses Post-Lung Transplant. Semin Respir Crit Care Med 2021;42:449-59. [PMID: 34030206 DOI: 10.1055/s-0041-1729172] [Reference Citation Analysis]
5 Kullar R, Patel AP, Saab S. COVID-19 in Liver Transplant Recipients. J Clin Transl Hepatol 2021;9:545-50. [PMID: 34447684 DOI: 10.14218/JCTH.2020.00098] [Reference Citation Analysis]
6 Zhang H, Dai H, Xie X. Solid Organ Transplantation During the COVID-19 Pandemic. Front Immunol 2020;11:1392. [PMID: 32612614 DOI: 10.3389/fimmu.2020.01392] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
7 Molnar MZ, Bhalla A, Azhar A, Tsujita M, Talwar M, Balaraman V, Sodhi A, Kadaria D, Eason JD, Hayek SS, Coca SG, Shaefi S, Neyra JA, Gupta S, Leaf DE, Kovesdy CP; STOP-COVID Investigators. Outcomes of critically ill solid organ transplant patients with COVID-19 in the United States. Am J Transplant 2020;20:3061-71. [PMID: 32844546 DOI: 10.1111/ajt.16280] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 18.0] [Reference Citation Analysis]
8 Silvano J, Ferreira F, Bustorff M, Nunes AT, Tavares I, Sobrinho Simões J, Ramos A, Cardoso MJ, Sampaio S, Pestana M. Viral Clearance and Serological Response to SARS-CoV-2 in Kidney Transplant Recipients. Transplant Proc 2021;53:1180-6. [PMID: 33419577 DOI: 10.1016/j.transproceed.2020.11.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
9 Bitencourt L, Pedrosa AL, de Brito SBCS, Fróes ACF, de Carvalho ST, Fonseca GG, Ferreira GC, Fradico PF, Simões E Silva AC. COVID-19 and Renal Diseases: An Update. Curr Drug Targets 2021;22:52-67. [PMID: 33050860 DOI: 10.2174/1389450121999201013151300] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
10 Bery AI, Kulkarni HS, Kreisel D. Editorial: COVID-19 immunology and organ transplantation. Curr Opin Organ Transplant 2021;26:258-65. [PMID: 33651004 DOI: 10.1097/MOT.0000000000000862] [Reference Citation Analysis]
11 Moosavi SA, Mashhadiagha A, Motazedian N, Hashemazar A, Hoveidaei AH, Bolignano D. COVID-19 clinical manifestations and treatment strategies among solid-organ recipients: A systematic review of cases. Transpl Infect Dis 2020;22:e13427. [PMID: 32779820 DOI: 10.1111/tid.13427] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
12 Munting A, Manuel O. Viral infections in lung transplantation. J Thorac Dis 2021;13:6673-94. [PMID: 34992844 DOI: 10.21037/jtd-2021-24] [Reference Citation Analysis]
13 Lhuillier E, Patout M, Marino P, Arbane G, Murphy PB, Roux A, Thabut G, Castier Y, Mal H, Brugiere O. Current Practices in the Management of Respiratory Virus Infections in Lung Transplantation: A European Survey of Clinical Practice. Transplantation 2020;104:e183-4. [PMID: 31895338 DOI: 10.1097/TP.0000000000003098] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Zhong Z, Zhang Q, Xia H, Wang A, Liang W, Zhou W, Zhou L, Liu X, Rao L, Li Z, Peng Z, Mo P, Xiong Y, Ye S, Wang Y, Ye Q. Clinical characteristics and immunosuppressant management of coronavirus disease 2019 in solid organ transplant recipients. Am J Transplant. 2020;20:1916-1921. [PMID: 32282986 DOI: 10.1111/ajt.15928] [Cited by in Crossref: 69] [Cited by in F6Publishing: 67] [Article Influence: 34.5] [Reference Citation Analysis]
15 Alattar RA, Shaar SH, Othman M, Abu Jarir SH, Hashim SM, Iqbal F, Rustom F, Almaslamani MA, Omrani AS. Coronavirus disease 2019 in solid organ transplant recipients in the setting of proactive screening and contact tracing of Qatar. Qatar Med J 2021;2021:23. [PMID: 34604011 DOI: 10.5339/qmj.2021.23] [Reference Citation Analysis]
16 Ison MG, Hirsch HH. Community-Acquired Respiratory Viruses in Transplant Patients: Diversity, Impact, Unmet Clinical Needs. Clin Microbiol Rev 2019;32:e00042-19. [PMID: 31511250 DOI: 10.1128/CMR.00042-19] [Cited by in Crossref: 41] [Cited by in F6Publishing: 21] [Article Influence: 13.7] [Reference Citation Analysis]
17 Chandorkar A, Coro A, Natori Y, Anjan S, Abbo LM, Guerra G, Mattiazzi AD, Mendez-Castaner LA, Morris MI, Camargo JF, Vianna R, Simkins J. Kidney transplantation during coronavirus 2019 pandemic at a large hospital in Miami. Transpl Infect Dis 2020;22:e13416. [PMID: 32681708 DOI: 10.1111/tid.13416] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
18 Fung M, Babik JM. COVID-19 in Immunocompromised Hosts: What We Know So Far. Clin Infect Dis. 2021;72:340-350. [PMID: 33501974 DOI: 10.1093/cid/ciaa863] [Cited by in Crossref: 95] [Cited by in F6Publishing: 99] [Article Influence: 95.0] [Reference Citation Analysis]
19 Bazemore K, Rohly M, Permpalung N, Yu K, Timofte I, Brown AW, Orens J, Iacono A, Nathan SD, Avery RK, Valantine H, Agbor-Enoh S, Shah PD. Donor derived cell free DNA% is elevated with pathogens that are risk factors for acute and chronic lung allograft injury. J Heart Lung Transplant 2021:S1053-2498(21)02326-3. [PMID: 34344623 DOI: 10.1016/j.healun.2021.05.012] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
20 Smith CJ, McCulloch MD, Shirley DA, L'Ecuyer TJ. Pediatric heart transplant from an incompletely treated influenza A-positive donor. Pediatr Transplant 2019;23:e13585. [PMID: 31515860 DOI: 10.1111/petr.13585] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Ju CR, Lian QY, Zhang JH, Qiu T, Cai ZT, Jiang WY, Zhang J, Cheng Q, Chen G, Li N, Wang CY, He JX. Recommended prophylactic and management strategies for severe acute respiratory syndrome coronavirus 2 infection in transplant recipients. Chronic Dis Transl Med 2020;6:87-97. [PMID: 32363045 DOI: 10.1016/j.cdtm.2020.02.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 4.5] [Reference Citation Analysis]
22 Esagian SM, Ziogas IA, Giannis D, Hayat MH, Elias N, Tsoulfas G. Challenges in Abdominal Organ Transplantation During the COVID-19 Pandemic. Front Med (Lausanne) 2020;7:287. [PMID: 32582741 DOI: 10.3389/fmed.2020.00287] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
23 Bitterman R, Kumar D. Respiratory Viruses in Solid Organ Transplant Recipients. Viruses 2021;13:2146. [PMID: 34834953 DOI: 10.3390/v13112146] [Reference Citation Analysis]
24 Villanueva DH, Arcega V, Rao M. Review of respiratory syncytial virus infection among older adults and transplant recipients. Therapeutic Advances in Infection 2022;9:204993612210914. [DOI: 10.1177/20499361221091413] [Reference Citation Analysis]
25 Dakowitz M, Korus J, Mazanowska O, Krajewska M, Kamińska D. Co-Infection of COVID-19 and Pneumocystosis Following Rituximab Infusion—A Case Report. Transplantology 2022;3:83-90. [DOI: 10.3390/transplantology3010008] [Reference Citation Analysis]
26 Yang Y, Iwasaki A. Impact of Chronic HIV Infection on SARS-CoV-2 Infection, COVID-19 Disease and Vaccines. Curr HIV/AIDS Rep 2021. [PMID: 34843064 DOI: 10.1007/s11904-021-00590-x] [Reference Citation Analysis]
27 Modi AR, Koval CE, Taege AJ, Modaresi Esfeh J, Eghtesad B, Narayanan Menon KV, Quintini C, Miller C. Coronavirus disease 2019 in an orthotopic liver transplant recipient living with human immunodeficiency virus. Transpl Infect Dis 2020;22:e13351. [PMID: 32500666 DOI: 10.1111/tid.13351] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
28 Manuel O, Estabrook M; American Society of Transplantation Infectious Diseases Community of Practice. RNA respiratory viral infections in solid organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant 2019;33:e13511. [PMID: 30817023 DOI: 10.1111/ctr.13511] [Cited by in Crossref: 63] [Cited by in F6Publishing: 47] [Article Influence: 21.0] [Reference Citation Analysis]
29 Otto WR, Green A. Antiviral Therapeutics in Pediatric Transplant Recipients. Infectious Disease Clinics of North America 2022;36:125-46. [DOI: 10.1016/j.idc.2021.11.004] [Reference Citation Analysis]
30 Tschopp J, L'Huillier AG, Mombelli M, Mueller NJ, Khanna N, Garzoni C, Meloni D, Papadimitriou-Olivgeris M, Neofytos D, Hirsch HH, Schuurmans MM, Müller T, Berney T, Steiger J, Pascual M, Manuel O, van Delden C; Swiss Transplant Cohort Study (STCS). First experience of SARS-CoV-2 infections in solid organ transplant recipients in the Swiss Transplant Cohort Study. Am J Transplant 2020;20:2876-82. [PMID: 32412159 DOI: 10.1111/ajt.16062] [Cited by in Crossref: 54] [Cited by in F6Publishing: 53] [Article Influence: 27.0] [Reference Citation Analysis]
31 Lee ARYB, Wong SY, Chai LYA, Lee SC, Lee MX, Muthiah MD, Tay SH, Teo CB, Tan BKJ, Chan YH, Sundar R, Soon YY. Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis. BMJ 2022;376:e068632. [PMID: 35236664 DOI: 10.1136/bmj-2021-068632] [Reference Citation Analysis]
32 Hanson KE, Azar MM, Banerjee R, Chou A, Colgrove RC, Ginocchio CC, Hayden MK, Holodiny M, Jain S, Koo S, Levy J, Timbrook TT, Caliendo AM. Molecular Testing for Acute Respiratory Tract Infections: Clinical and Diagnostic Recommendations From the IDSA's Diagnostics Committee. Clin Infect Dis 2020;71:2744-51. [PMID: 32369578 DOI: 10.1093/cid/ciaa508] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 14.0] [Reference Citation Analysis]
33 Nam HH, Ison MG. Community-acquired respiratory viruses in solid organ transplant. Curr Opin Organ Transplant 2019;24:483-9. [PMID: 31145157 DOI: 10.1097/MOT.0000000000000663] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
34 Fung M, Chiu CY, DeVoe C, Doernberg SB, Schwartz BS, Langelier C, Henrich TJ, Yokoe D, Davis J, Hays SR, Chandran S, Kukreja J, Ng D, Prostko J, Taylor R, Reyes K, Bainbridge E, Bond A, Chin-Hong P, Babik JM. Clinical outcomes and serologic response in solid organ transplant recipients with COVID-19: A case series from the United States. Am J Transplant 2020;20:3225-33. [PMID: 32476258 DOI: 10.1111/ajt.16079] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 18.5] [Reference Citation Analysis]
35 Mardani M, Hakamifard A. COVID-19 and immunocompromised conditions: Ongoing challenging issue. Eur J Inflamm 2021;19:205873922110161. [DOI: 10.1177/20587392211016114] [Reference Citation Analysis]
36 Kong D, Li M, Gong W. SARS-Cov-2 infection in transplant-related biology: Where do we stand? Ann Transplant 2020;25:e924768. [PMID: 33372171 DOI: 10.12659/AOT.924768] [Reference Citation Analysis]
37 Krasnow MR, Litt HK, Lehmann CJ, Lio J, Zhu M, Sherer R. Cancer, transplant, and immunocompromising conditions were not significantly associated with severe illness or death in hospitalized COVID-19 patients. J Clin Virol 2021;140:104850. [PMID: 34022753 DOI: 10.1016/j.jcv.2021.104850] [Reference Citation Analysis]
38 Nam HH, Ison MG. Respiratory Syncytial Virus. Semin Respir Crit Care Med 2021;42:788-99. [PMID: 34918321 DOI: 10.1055/s-0041-1736182] [Reference Citation Analysis]
39 Johnson KM, Belfer JJ, Peterson GR, Boelkins MR, Dumkow LE. Managing COVID-19 in Renal Transplant Recipients: A Review of Recent Literature and Case Supporting Corticosteroid-sparing Immunosuppression. Pharmacotherapy 2020;40:517-24. [PMID: 32339304 DOI: 10.1002/phar.2410] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 21.5] [Reference Citation Analysis]
40 Granger C, Guedeney P, Arnaud C, Guendouz S, Cimadevilla C, Kerneis M, Kerneis C, Zeitouni M, Verdonk C, Legeai C, Lebreton G, Leprince P, Désiré E, Sorrentino S, Silvain J, Montalescot G, Hazan F, Varnous S, Dorent R. Clinical manifestations and outcomes of coronavirus disease-19 in heart transplant recipients: a multicentre case series with a systematic review and meta-analysis. Transpl Int 2021;34:721-31. [PMID: 33539616 DOI: 10.1111/tri.13837] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
41 Puius YA, Bartash RM, Zingman BS. Maintaining mask momentum in transplant recipients. Transpl Infect Dis 2021. [PMID: 34324251 DOI: 10.1111/tid.13697] [Reference Citation Analysis]
42 Testaert H, Bouet M, Valour F, Gigandon A, Lafon ME, Philit F, Sénéchal A, Casalegno JS, Blanchard E, Le Pavec J, Ader F. Incidence, management and outcome of respiratory syncytial virus infection in adult lung transplant recipients: a 9-year retrospective multicentre study. Clin Microbiol Infect 2021;27:897-903. [PMID: 32827713 DOI: 10.1016/j.cmi.2020.07.050] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
43 Tejada S, Campogiani L, Mazo C, Romero A, Peña Y, Pont T, Gómez A, Román A, Rello J. Acute respiratory failure among lung transplant adults requiring intensive care: Changing spectrum of causative organisms and impact of procalcitonin test in the diagnostic workup. Transpl Infect Dis 2020;22:e13346. [PMID: 32473604 DOI: 10.1111/tid.13346] [Reference Citation Analysis]
44 de Zwart AES, Riezebos-Brilman A, Alffenaar JC, van den Heuvel ER, Gan CT, van der Bij W, Kerstjens HAM, Verschuuren EAM. Evaluation of 10 years of parainfluenza virus, human metapneumovirus, and respiratory syncytial virus infections in lung transplant recipients. Am J Transplant 2020;20:3529-37. [PMID: 32449200 DOI: 10.1111/ajt.16073] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
45 Seminari E, Colaneri M, Sambo M, Gallazzi I, Di Matteo A, Roda S, Bruno R; COVID19 IRCCS San Matteo Pavia Task Force. SARS Cov-2 infection in a renal-transplanted patient: A case report. Am J Transplant 2020;20:1882-4. [PMID: 32243672 DOI: 10.1111/ajt.15902] [Cited by in Crossref: 53] [Cited by in F6Publishing: 47] [Article Influence: 26.5] [Reference Citation Analysis]
46 Kim MY, Brennan DC, Shah P. General Approach to the Clinical Care of Solid Organ Transplant Recipients with COVID-19 Infection: Management for Transplant Recipients. Curr Transplant Rep 2020;:1-13. [PMID: 33145146 DOI: 10.1007/s40472-020-00305-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
47 Vaid N, Ardissino M, Reed TAN, Goodall J, Utting P, Miscampbell M, Condurache D, Cohen DL. Clinical characteristics and outcomes of immunosuppressed patients hospitalized with COVID-19: experience from London. J Intern Med 2021;289:385-94. [PMID: 32902028 DOI: 10.1111/joim.13172] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
48 Mombelli M, Kampouri E, Manuel O. Influenza in solid organ transplant recipients: epidemiology, management, and outcomes. Expert Review of Anti-infective Therapy 2020;18:103-12. [DOI: 10.1080/14787210.2020.1713098] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
49 Epstein RL, Sperring H, Hofman M, Lodi S, White LF, Barocas JA, Bouton TC, Xiao Y, Hsu HE, Miller NS, Linas BP, Marathe JG. Time to SARS-CoV-2 PCR Clearance in Immunocompromising Conditions: Is Test-Based Removal From Isolation Necessary in Severely Immunocompromised Individuals? Open Forum Infect Dis 2021;8:ofab164. [PMID: 34189164 DOI: 10.1093/ofid/ofab164] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
50 Ganjei Z, Faraji Dana H, Ebrahimi-Dehkordi S, Alidoust F, Bahmani K. Methotrexate as a safe immunosuppressive agent during the COVID-19 pandemic. Int Immunopharmacol 2021;101:108324. [PMID: 34731780 DOI: 10.1016/j.intimp.2021.108324] [Reference Citation Analysis]
51 Miarons M, Larrosa-García M, García-García S, Los-Arcos I, Moreso F, Berastegui C, Castells L, Pérez-Hoyos S, Varela J, Pau-Parra A, Varón-Galcera C, Parramon-Teixidó CJ, Martínez-Casanova J, Domènech L, García-Ortega P, Sánchez-Sancho P, Alonso-Martínez C, Gómez-Ganda L, Roch-Santed M, Gracia-Moya A, Del-Rio-Gutiérrez JM, Guillén-Del-Castillo A, Sans-Pola C, Antón A, Montoro B, Gorgas-Torner MQ; Vall d’Hebron COVID-19 Working Group. COVID-19 in Solid Organ Transplantation: A Matched Retrospective Cohort Study and Evaluation of Immunosuppression Management. Transplantation 2021;105:138-50. [PMID: 32941394 DOI: 10.1097/TP.0000000000003460] [Cited by in Crossref: 17] [Cited by in F6Publishing: 7] [Article Influence: 17.0] [Reference Citation Analysis]
52 Oh TK, Song IA, Lee J, Eom W, Jeon YT. Musculoskeletal Disorders, Pain Medication, and in-Hospital Mortality among Patients with COVID-19 in South Korea: A Population-Based Cohort Study. Int J Environ Res Public Health 2021;18:6804. [PMID: 34202825 DOI: 10.3390/ijerph18136804] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
53 Antony SJ, Singh J, de Jesus M, Lance J. Early use of tocilizumab in respiratory failure associated with acute COVID -19 pneumonia in recipients with solid organ transplantation. IDCases 2020;21:e00888. [PMID: 32685369 DOI: 10.1016/j.idcr.2020.e00888] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
54 Contributors to the C4 article. C4 article: Implications of COVID-19 in transplantation. Am J Transplant 2021;21:1801-15. [PMID: 33040483 DOI: 10.1111/ajt.16346] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
55 de St Maurice A, Halasa N. Preparing for the 2019-2020 influenza season. Pediatr Transplant 2020;24:e13645. [PMID: 31885157 DOI: 10.1111/petr.13645] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
56 Samannodi M, Vaghefi-Hosseini R, Nigo M, Guevara EY, Hasbun R. Risk Classification for Respiratory Viral Infections in Adult Solid Organ Transplantation Recipients. Transplant Proc 2021;53:737-42. [PMID: 33272649 DOI: 10.1016/j.transproceed.2020.10.011] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
57 Benotmane I, Gautier-Vargas G, Wendling MJ, Perrin P, Velay A, Bassand X, Bedo D, Baldacini C, Sagnard M, Bozman DF, Della-Chiesa M, Solis M, Gallais F, Cognard N, Olagne J, Delagrèverie H, Gontard L, Panaget B, Marx D, Heibel F, Braun-Parvez L, Moulin B, Caillard S, Fafi-Kremer S. In-depth virological assessment of kidney transplant recipients with COVID-19. Am J Transplant 2020;20:3162-72. [PMID: 32777130 DOI: 10.1111/ajt.16251] [Cited by in Crossref: 22] [Cited by in F6Publishing: 28] [Article Influence: 11.0] [Reference Citation Analysis]
58 Goldman JD, Robinson PC, Uldrick TS, Ljungman P. COVID-19 in immunocompromised populations: implications for prognosis and repurposing of immunotherapies. J Immunother Cancer 2021;9:e002630. [PMID: 34117116 DOI: 10.1136/jitc-2021-002630] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
59 Nam HH, Ison MG. Respiratory syncytial virus infection in adults. BMJ. [DOI: 10.1136/bmj.l5021] [Cited by in Crossref: 39] [Cited by in F6Publishing: 32] [Article Influence: 13.0] [Reference Citation Analysis]
60 Filippidis P, Vionnet J, Manuel O, Mombelli M. Prevention of viral infections in solid organ transplant recipients in the era of COVID-19: a narrative review. Expert Rev Anti Infect Ther 2021;:1-18. [PMID: 34854329 DOI: 10.1080/14787210.2022.2013808] [Reference Citation Analysis]